Q3 EPS Forecast for USANA Health Sciences Lifted by Analyst

USANA Health Sciences, Inc. (NYSE:USNA) – Equities researchers at Sidoti Csr raised their Q3 2025 earnings estimates for shares of USANA Health Sciences in a research report issued to clients and investors on Wednesday, February 26th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will earn $0.72 per share for the quarter, up from their previous forecast of $0.70. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q3 2025 earnings at $0.72 EPS, Q3 2026 earnings at $0.98 EPS and Q3 2026 earnings at $0.98 EPS.

Other research analysts have also recently issued research reports about the stock. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. Finally, DA Davidson reduced their target price on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday.

USANA Health Sciences Price Performance

USANA Health Sciences stock opened at $28.57 on Friday. The company has a market capitalization of $544.54 million, a PE ratio of 10.10, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. The business has a 50 day simple moving average of $33.50 and a 200 day simple moving average of $36.56. USANA Health Sciences has a one year low of $27.71 and a one year high of $50.32.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million.

Institutional Investors Weigh In On USANA Health Sciences

Several large investors have recently made changes to their positions in USNA. Public Employees Retirement System of Ohio raised its holdings in shares of USANA Health Sciences by 635.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company’s stock valued at $182,000 after purchasing an additional 4,385 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in USANA Health Sciences by 83.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,300 shares of the company’s stock valued at $621,000 after purchasing an additional 7,877 shares during the last quarter. Millennium Management LLC bought a new stake in shares of USANA Health Sciences during the 4th quarter worth about $633,000. Lazard Asset Management LLC boosted its holdings in shares of USANA Health Sciences by 24,765.5% during the fourth quarter. Lazard Asset Management LLC now owns 7,211 shares of the company’s stock worth $258,000 after acquiring an additional 7,182 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its stake in USANA Health Sciences by 16.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company’s stock valued at $4,629,000 after purchasing an additional 18,490 shares during the period. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.